GSK/Biovail Wellbutrin XL “approvable”
Executive Summary
GlaxoSmithKline/Biovail receive "approvable" letter from FDA for Wellbutrin XL. Biovail says letter involves "resolution of routine matters"; company will submit response to the agency "promptly." Biovail still expects approval during the second half of 2003...
GlaxoSmithKline/Biovail receive "approvable" letter from FDA for Wellbutrin XL . Biovail says letter involves "resolution of routine matters"; company will submit response to the agency "promptly." Biovail still expects approval during the second half of 2003.... |